Analysis Of Diet, Risk Factors, Treatment Profile and Complications of Diabetes in Surat City

Authors

  • Vivek K Choksi SMIMER, Surat
  • Kairavee D Dave SMIMER, Surat
  • Shaishav J Panchal SMIMER, Surat

Keywords:

Diabetes, diet, complications, treatment

Abstract

This study was conducted among 69 known diabetes patients regarding diet, habits, risk factors, complications and treatment. We found that all the respondents were aware of the complications related to Diabetes. The diagnosis made by routine checkup was in 66.6% and by presenting complaints only 26% which showed that as diabetes is asymptomatic, its diagnosis is made late and patients are more prone to complications.

References

Harris MI. Summary. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases; 1995:1-13.

Economic consequences of diabetes mellitus in the US in 2002. American Diabetes Association Diabetes Care. 2003; 26 :917-932.

Klein R, Klein BEK. Vision disorders in diabetes. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases; 1995:293-338.

Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995; 18:258-268.

Eastman RC. Neuropathy in diabetes. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases; 1995:339-348.

Wingard D, Barrett-Connor E. Heart disease and diabetes. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, Md: National Institute of Diabetes and Digestive and Kidney Diseases; 1995:429-448.

Stratton IM, Adler AI, Neil HA, et al. Association of glycemia and macrovascular and microvascular complications in type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412.

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-986.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group. Lancet. 1998;352:837-853.

Wei M, Gaskill SP, Haffner SM, et al. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality: the San Antonio Heart Study. Diabetes Care. 1998;21:1167-1172.

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. JAMA. 2002;287:2563-2569.

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med. 2003;348:2294-2303.

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UK Prospective Diabetes Study (UKPDS) Group. UKPDS 38. BMJ. 1998;317:703-713.

Hansson I, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.

Pyorala K, Pedersen TR, Kjekshus J, et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997;20:614-620.

Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. CDC Diabetes Cost-effectiveness Group. JAMA. 2002;287:2542-2551.

Standards of medical care for patients with diabetes mellitus. American Diabetes Association. Diabetes Care. 2003;26(suppl 1):S33-S50.

Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC VII Report. JAMA. 2003;289:2560-2572.

National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.

King H, Aubert R E, Herman W. H, Global burden of diabetes, 1995-2025, prevalence, numerical estimates and projection, Diabetes care 1998;21:1414-31.

King H, Rewers, M, WHO ad hoc diabetes reporting group, global estimates for prevalence of diabetes and IGT in adults, Diabetes Care 1993;16:157-77.

Lick diabetes with ice-cream and dark chocolate, The Pedestrian a quarterly journal, Midwest girl, may22, 2006

Dianne M. Demink, The latest scoop on ice-cream, diabetes health, September 22, 2008.

Downloads

Published

2011-09-30

How to Cite

1.
Choksi VK, Dave KD, Panchal SJ. Analysis Of Diet, Risk Factors, Treatment Profile and Complications of Diabetes in Surat City. Natl J Community Med [Internet]. 2011 Sep. 30 [cited 2024 May 3];2(02):306-10. Available from: https://njcmindia.com/index.php/file/article/view/1904

Issue

Section

Original Research Articles